1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Kazakhstan Pharmaceuticals and Healthcare Report Q3 2016

Kazakhstan Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 76 pages

Includes 3 FREE quarterly updates

BMI View: The mid-term outlook for Kazakhstan's pharmaceutical and healthcare markets is mixed. Thehealthcare system is set to improve, with the introduction of a public health insurance system and e-healthtechnology; however, the formation of the Eurasian Economic Union medicines market is facing ongoingdelays. Moreover the country's poor regulatory environment and intellectual property respect will continueto present challenges for innovative drugmakers.

Headline Expenditure Projections

-Pharmaceuticals: KZT349.57bn (USD1.57bn) in 2015 to KZT381.54bn (USD1.13bn) in 2016; +9.2%in local currency terms and -28.0% in US dollar terms. Forecast in line with last quarter.

-Healthcare: KZT1.91trn (USD8.58bn) in 2015 to KZT2.18trn (USD6.45bn) in 2016; +13.9% in localcurrency terms and -24.9% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Kazakhstan Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Kazakhstan 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kazakhstan 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020) 18
Prescription Drug Market 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Kazakhstan 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Kazakhstan 2014-2020) 31
Industry Risk/Reward Index 32
Central And Eastern Europe Risk/Reward Index - Q3 2016 32
Kazakhstan Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 41
Pricing And Reimbursement Regime 43
Market Overview 46
Healthcare Sector 47
Clinical Trials 50
Epidemiology 50
Competitive Landscape 53
Research-Based Industry 53
Table: Multinational Market Activity 57
Pharmaceutical Distribution 58
Pharmaceutical Retail Sector 60
Company Profile 61
Chimpharm 61
Romat 63
Demographic Forecast 65
Demographic Outlook 65
Table: Population Headline Indicators (Kazakhstan 1990-2025) 66
Table: Key Population Ratios (Kazakhstan 1990-2025) 66
Table: Urban/Rural Population and Life Expectancy (Kazakhstan 1990-2025) 67
Table: Population By Age Group (Kazakhstan 1990-2025) 67
Table: Population By Age Group % (Kazakhstan 1990-2025) 68
Glossary 70
Methodology 72
Pharmaceutical Expenditure Forecast Model 72
Healthcare Expenditure Forecast Model 72
Notes On Methodology 73
Risk/Reward Index Methodology 74
Index Overview 75
Table: Pharmaceutical Risk/Reward Index Indicators 75
Indicator Weightings 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.